nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—connective tissue—systemic scleroderma	0.0379	0.255	CbGeAlD
Icosapent ethyl—DGAT1—skin of body—systemic scleroderma	0.0342	0.231	CbGeAlD
Icosapent ethyl—DGAT1—digestive system—systemic scleroderma	0.0274	0.184	CbGeAlD
Icosapent ethyl—DGAT1—tendon—systemic scleroderma	0.026	0.176	CbGeAlD
Icosapent ethyl—DGAT1—lung—systemic scleroderma	0.0228	0.154	CbGeAlD
Icosapent ethyl—Decreased appetite—Captopril—systemic scleroderma	0.00108	0.00127	CcSEcCtD
Icosapent ethyl—Malaise—Mycophenolic acid—systemic scleroderma	0.00108	0.00127	CcSEcCtD
Icosapent ethyl—Malnutrition—Lisinopril—systemic scleroderma	0.00108	0.00127	CcSEcCtD
Icosapent ethyl—Infection—Azathioprine—systemic scleroderma	0.00108	0.00127	CcSEcCtD
Icosapent ethyl—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00127	CcSEcCtD
Icosapent ethyl—Vertigo—Mycophenolic acid—systemic scleroderma	0.00108	0.00127	CcSEcCtD
Icosapent ethyl—Syncope—Mycophenolic acid—systemic scleroderma	0.00108	0.00126	CcSEcCtD
Icosapent ethyl—Chest pain—Leflunomide—systemic scleroderma	0.00107	0.00126	CcSEcCtD
Icosapent ethyl—Arthralgia—Leflunomide—systemic scleroderma	0.00107	0.00126	CcSEcCtD
Icosapent ethyl—Myalgia—Leflunomide—systemic scleroderma	0.00107	0.00126	CcSEcCtD
Icosapent ethyl—Constipation—Captopril—systemic scleroderma	0.00107	0.00125	CcSEcCtD
Icosapent ethyl—Dysgeusia—Lisinopril—systemic scleroderma	0.00106	0.00124	CcSEcCtD
Icosapent ethyl—Discomfort—Leflunomide—systemic scleroderma	0.00106	0.00124	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00106	0.00124	CcSEcCtD
Icosapent ethyl—Affect lability—Prednisone—systemic scleroderma	0.00105	0.00123	CcSEcCtD
Icosapent ethyl—Dry mouth—Leflunomide—systemic scleroderma	0.00105	0.00123	CcSEcCtD
Icosapent ethyl—Cough—Mycophenolic acid—systemic scleroderma	0.00105	0.00123	CcSEcCtD
Icosapent ethyl—Back pain—Lisinopril—systemic scleroderma	0.00105	0.00123	CcSEcCtD
Icosapent ethyl—Vomiting—Pentoxifylline—systemic scleroderma	0.00105	0.00123	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Methotrexate—systemic scleroderma	0.00104	0.00123	CcSEcCtD
Icosapent ethyl—Rash—Pentoxifylline—systemic scleroderma	0.00104	0.00122	CcSEcCtD
Icosapent ethyl—Hypertension—Mycophenolic acid—systemic scleroderma	0.00104	0.00122	CcSEcCtD
Icosapent ethyl—Dermatitis—Pentoxifylline—systemic scleroderma	0.00104	0.00122	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00103	0.00121	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Captopril—systemic scleroderma	0.00103	0.00121	CcSEcCtD
Icosapent ethyl—Chest pain—Mycophenolic acid—systemic scleroderma	0.00102	0.0012	CcSEcCtD
Icosapent ethyl—Myalgia—Mycophenolic acid—systemic scleroderma	0.00102	0.0012	CcSEcCtD
Icosapent ethyl—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00102	0.0012	CcSEcCtD
Icosapent ethyl—Infection—Leflunomide—systemic scleroderma	0.00102	0.0012	CcSEcCtD
Icosapent ethyl—Asthenia—Mometasone—systemic scleroderma	0.00102	0.0012	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Prednisone—systemic scleroderma	0.00101	0.00119	CcSEcCtD
Icosapent ethyl—Mood swings—Prednisone—systemic scleroderma	0.00101	0.00119	CcSEcCtD
Icosapent ethyl—Discomfort—Mycophenolic acid—systemic scleroderma	0.00101	0.00119	CcSEcCtD
Icosapent ethyl—Pruritus—Mometasone—systemic scleroderma	0.001	0.00118	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Lisinopril—systemic scleroderma	0.001	0.00118	CcSEcCtD
Icosapent ethyl—Tachycardia—Leflunomide—systemic scleroderma	0.001	0.00118	CcSEcCtD
Icosapent ethyl—Dry mouth—Mycophenolic acid—systemic scleroderma	0.001	0.00117	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000993	0.00117	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000991	0.00116	CcSEcCtD
Icosapent ethyl—Body temperature increased—Captopril—systemic scleroderma	0.000985	0.00116	CcSEcCtD
Icosapent ethyl—Oedema—Mycophenolic acid—systemic scleroderma	0.00098	0.00115	CcSEcCtD
Icosapent ethyl—Anorexia—Leflunomide—systemic scleroderma	0.000979	0.00115	CcSEcCtD
Icosapent ethyl—Chills—Mycophenolate mofetil—systemic scleroderma	0.000977	0.00115	CcSEcCtD
Icosapent ethyl—Malaise—Lisinopril—systemic scleroderma	0.000975	0.00115	CcSEcCtD
Icosapent ethyl—Infection—Mycophenolic acid—systemic scleroderma	0.000973	0.00114	CcSEcCtD
Icosapent ethyl—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000972	0.00114	CcSEcCtD
Icosapent ethyl—Vertigo—Lisinopril—systemic scleroderma	0.000972	0.00114	CcSEcCtD
Icosapent ethyl—Syncope—Lisinopril—systemic scleroderma	0.00097	0.00114	CcSEcCtD
Icosapent ethyl—Shock—Mycophenolic acid—systemic scleroderma	0.000964	0.00113	CcSEcCtD
Icosapent ethyl—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000962	0.00113	CcSEcCtD
Icosapent ethyl—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000956	0.00112	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Lisinopril—systemic scleroderma	0.00095	0.00112	CcSEcCtD
Icosapent ethyl—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000948	0.00111	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000947	0.00111	CcSEcCtD
Icosapent ethyl—Cough—Lisinopril—systemic scleroderma	0.000944	0.00111	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000941	0.0011	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000939	0.0011	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000936	0.0011	CcSEcCtD
Icosapent ethyl—Anorexia—Mycophenolic acid—systemic scleroderma	0.000934	0.0011	CcSEcCtD
Icosapent ethyl—Insomnia—Leflunomide—systemic scleroderma	0.000929	0.00109	CcSEcCtD
Icosapent ethyl—Abdominal distension—Prednisone—systemic scleroderma	0.000928	0.00109	CcSEcCtD
Icosapent ethyl—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000928	0.00109	CcSEcCtD
Icosapent ethyl—Myalgia—Lisinopril—systemic scleroderma	0.000921	0.00108	CcSEcCtD
Icosapent ethyl—Arthralgia—Lisinopril—systemic scleroderma	0.000921	0.00108	CcSEcCtD
Icosapent ethyl—Chest pain—Lisinopril—systemic scleroderma	0.000921	0.00108	CcSEcCtD
Icosapent ethyl—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000917	0.00108	CcSEcCtD
Icosapent ethyl—Dyspnoea—Leflunomide—systemic scleroderma	0.000916	0.00108	CcSEcCtD
Icosapent ethyl—Discomfort—Lisinopril—systemic scleroderma	0.00091	0.00107	CcSEcCtD
Icosapent ethyl—Dyspepsia—Leflunomide—systemic scleroderma	0.000904	0.00106	CcSEcCtD
Icosapent ethyl—Pancreatitis—Prednisone—systemic scleroderma	0.000904	0.00106	CcSEcCtD
Icosapent ethyl—Vomiting—Mometasone—systemic scleroderma	0.000902	0.00106	CcSEcCtD
Icosapent ethyl—Dry mouth—Lisinopril—systemic scleroderma	0.0009	0.00106	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Azathioprine—systemic scleroderma	0.000896	0.00105	CcSEcCtD
Icosapent ethyl—Rash—Mometasone—systemic scleroderma	0.000895	0.00105	CcSEcCtD
Icosapent ethyl—Asthenia—Captopril—systemic scleroderma	0.000894	0.00105	CcSEcCtD
Icosapent ethyl—Dermatitis—Mometasone—systemic scleroderma	0.000894	0.00105	CcSEcCtD
Icosapent ethyl—Decreased appetite—Leflunomide—systemic scleroderma	0.000893	0.00105	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000893	0.00105	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000887	0.00104	CcSEcCtD
Icosapent ethyl—Insomnia—Mycophenolic acid—systemic scleroderma	0.000886	0.00104	CcSEcCtD
Icosapent ethyl—Oedema—Lisinopril—systemic scleroderma	0.000883	0.00104	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000883	0.00104	CcSEcCtD
Icosapent ethyl—Pruritus—Captopril—systemic scleroderma	0.000882	0.00104	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000879	0.00103	CcSEcCtD
Icosapent ethyl—Constipation—Leflunomide—systemic scleroderma	0.000878	0.00103	CcSEcCtD
Icosapent ethyl—Pain—Leflunomide—systemic scleroderma	0.000878	0.00103	CcSEcCtD
Icosapent ethyl—Infection—Lisinopril—systemic scleroderma	0.000877	0.00103	CcSEcCtD
Icosapent ethyl—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000874	0.00103	CcSEcCtD
Icosapent ethyl—Shock—Lisinopril—systemic scleroderma	0.000868	0.00102	CcSEcCtD
Icosapent ethyl—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000863	0.00101	CcSEcCtD
Icosapent ethyl—Tachycardia—Lisinopril—systemic scleroderma	0.000861	0.00101	CcSEcCtD
Icosapent ethyl—Body temperature increased—Azathioprine—systemic scleroderma	0.00086	0.00101	CcSEcCtD
Icosapent ethyl—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000854	0.001	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000853	0.001	CcSEcCtD
Icosapent ethyl—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000852	0.001	CcSEcCtD
Icosapent ethyl—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000851	0.001	CcSEcCtD
Icosapent ethyl—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00085	0.000998	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Prednisone—systemic scleroderma	0.000849	0.000997	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Leflunomide—systemic scleroderma	0.000846	0.000994	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000846	0.000993	CcSEcCtD
Icosapent ethyl—Mood swings—Methotrexate—systemic scleroderma	0.000844	0.000991	CcSEcCtD
Icosapent ethyl—Anorexia—Lisinopril—systemic scleroderma	0.000841	0.000988	CcSEcCtD
Icosapent ethyl—Constipation—Mycophenolic acid—systemic scleroderma	0.000838	0.000984	CcSEcCtD
Icosapent ethyl—Pain—Mycophenolic acid—systemic scleroderma	0.000838	0.000984	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000833	0.000978	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Prednisone—systemic scleroderma	0.000831	0.000976	CcSEcCtD
Icosapent ethyl—Cough—Mycophenolate mofetil—systemic scleroderma	0.000827	0.000971	CcSEcCtD
Icosapent ethyl—Dizziness—Captopril—systemic scleroderma	0.000824	0.000968	CcSEcCtD
Icosapent ethyl—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000818	0.000961	CcSEcCtD
Icosapent ethyl—Body temperature increased—Leflunomide—systemic scleroderma	0.000812	0.000953	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00081	0.000951	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000807	0.000948	CcSEcCtD
Icosapent ethyl—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000807	0.000947	CcSEcCtD
Icosapent ethyl—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000807	0.000947	CcSEcCtD
Icosapent ethyl—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000807	0.000947	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Prednisone—systemic scleroderma	0.000806	0.000946	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000804	0.000944	CcSEcCtD
Icosapent ethyl—Insomnia—Lisinopril—systemic scleroderma	0.000798	0.000937	CcSEcCtD
Icosapent ethyl—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000797	0.000936	CcSEcCtD
Icosapent ethyl—Vomiting—Captopril—systemic scleroderma	0.000792	0.00093	CcSEcCtD
Icosapent ethyl—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000789	0.000926	CcSEcCtD
Icosapent ethyl—Dyspnoea—Lisinopril—systemic scleroderma	0.000787	0.000924	CcSEcCtD
Icosapent ethyl—Rash—Captopril—systemic scleroderma	0.000786	0.000923	CcSEcCtD
Icosapent ethyl—Dermatitis—Captopril—systemic scleroderma	0.000785	0.000922	CcSEcCtD
Icosapent ethyl—Dyspepsia—Lisinopril—systemic scleroderma	0.000777	0.000912	CcSEcCtD
Icosapent ethyl—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000775	0.00091	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000773	0.000908	CcSEcCtD
Icosapent ethyl—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000773	0.000908	CcSEcCtD
Icosapent ethyl—Asthma—Methotrexate—systemic scleroderma	0.00077	0.000905	CcSEcCtD
Icosapent ethyl—Infection—Mycophenolate mofetil—systemic scleroderma	0.000768	0.000902	CcSEcCtD
Icosapent ethyl—Decreased appetite—Lisinopril—systemic scleroderma	0.000767	0.000901	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000762	0.000895	CcSEcCtD
Icosapent ethyl—Shock—Mycophenolate mofetil—systemic scleroderma	0.000761	0.000893	CcSEcCtD
Icosapent ethyl—Pancreatitis—Methotrexate—systemic scleroderma	0.000755	0.000887	CcSEcCtD
Icosapent ethyl—Pain—Lisinopril—systemic scleroderma	0.000755	0.000886	CcSEcCtD
Icosapent ethyl—Constipation—Lisinopril—systemic scleroderma	0.000755	0.000886	CcSEcCtD
Icosapent ethyl—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000755	0.000886	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000748	0.000878	CcSEcCtD
Icosapent ethyl—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000737	0.000865	CcSEcCtD
Icosapent ethyl—Asthenia—Leflunomide—systemic scleroderma	0.000737	0.000865	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Lisinopril—systemic scleroderma	0.000727	0.000854	CcSEcCtD
Icosapent ethyl—Pruritus—Leflunomide—systemic scleroderma	0.000727	0.000853	CcSEcCtD
Icosapent ethyl—Dizziness—Azathioprine—systemic scleroderma	0.000719	0.000845	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00071	0.000833	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000705	0.000827	CcSEcCtD
Icosapent ethyl—Asthenia—Mycophenolic acid—systemic scleroderma	0.000703	0.000825	CcSEcCtD
Icosapent ethyl—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000699	0.000821	CcSEcCtD
Icosapent ethyl—Body temperature increased—Lisinopril—systemic scleroderma	0.000698	0.000819	CcSEcCtD
Icosapent ethyl—Pruritus—Mycophenolic acid—systemic scleroderma	0.000693	0.000814	CcSEcCtD
Icosapent ethyl—Vomiting—Azathioprine—systemic scleroderma	0.000692	0.000812	CcSEcCtD
Icosapent ethyl—Pneumonia—Methotrexate—systemic scleroderma	0.000691	0.000811	CcSEcCtD
Icosapent ethyl—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000689	0.000809	CcSEcCtD
Icosapent ethyl—Infestation NOS—Methotrexate—systemic scleroderma	0.000687	0.000806	CcSEcCtD
Icosapent ethyl—Infestation—Methotrexate—systemic scleroderma	0.000687	0.000806	CcSEcCtD
Icosapent ethyl—Rash—Azathioprine—systemic scleroderma	0.000686	0.000805	CcSEcCtD
Icosapent ethyl—Dermatitis—Azathioprine—systemic scleroderma	0.000685	0.000804	CcSEcCtD
Icosapent ethyl—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000681	0.000799	CcSEcCtD
Icosapent ethyl—Dizziness—Leflunomide—systemic scleroderma	0.000679	0.000798	CcSEcCtD
Icosapent ethyl—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000672	0.000789	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000668	0.000784	CcSEcCtD
Icosapent ethyl—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000661	0.000776	CcSEcCtD
Icosapent ethyl—Pain—Mycophenolate mofetil—systemic scleroderma	0.000661	0.000776	CcSEcCtD
Icosapent ethyl—Arrhythmia—Prednisone—systemic scleroderma	0.000659	0.000774	CcSEcCtD
Icosapent ethyl—Sweating—Methotrexate—systemic scleroderma	0.000658	0.000773	CcSEcCtD
Icosapent ethyl—Vomiting—Leflunomide—systemic scleroderma	0.000653	0.000767	CcSEcCtD
Icosapent ethyl—Alopecia—Prednisone—systemic scleroderma	0.000652	0.000766	CcSEcCtD
Icosapent ethyl—Dizziness—Mycophenolic acid—systemic scleroderma	0.000648	0.000761	CcSEcCtD
Icosapent ethyl—Epistaxis—Methotrexate—systemic scleroderma	0.000648	0.000761	CcSEcCtD
Icosapent ethyl—Rash—Leflunomide—systemic scleroderma	0.000648	0.00076	CcSEcCtD
Icosapent ethyl—Dermatitis—Leflunomide—systemic scleroderma	0.000647	0.00076	CcSEcCtD
Icosapent ethyl—Malnutrition—Prednisone—systemic scleroderma	0.000642	0.000754	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000637	0.000748	CcSEcCtD
Icosapent ethyl—Asthenia—Lisinopril—systemic scleroderma	0.000633	0.000744	CcSEcCtD
Icosapent ethyl—Pruritus—Lisinopril—systemic scleroderma	0.000624	0.000733	CcSEcCtD
Icosapent ethyl—Vomiting—Mycophenolic acid—systemic scleroderma	0.000623	0.000732	CcSEcCtD
Icosapent ethyl—Rash—Mycophenolic acid—systemic scleroderma	0.000618	0.000725	CcSEcCtD
Icosapent ethyl—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000617	0.000725	CcSEcCtD
Icosapent ethyl—Pharyngitis—Methotrexate—systemic scleroderma	0.000612	0.000719	CcSEcCtD
Icosapent ethyl—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000611	0.000718	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Prednisone—systemic scleroderma	0.000596	0.0007	CcSEcCtD
Icosapent ethyl—Dizziness—Lisinopril—systemic scleroderma	0.000584	0.000685	CcSEcCtD
Icosapent ethyl—Malaise—Prednisone—systemic scleroderma	0.000579	0.00068	CcSEcCtD
Icosapent ethyl—Vertigo—Prednisone—systemic scleroderma	0.000577	0.000678	CcSEcCtD
Icosapent ethyl—Syncope—Prednisone—systemic scleroderma	0.000576	0.000676	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Prednisone—systemic scleroderma	0.000565	0.000663	CcSEcCtD
Icosapent ethyl—Vomiting—Lisinopril—systemic scleroderma	0.000561	0.000659	CcSEcCtD
Icosapent ethyl—Rash—Lisinopril—systemic scleroderma	0.000556	0.000653	CcSEcCtD
Icosapent ethyl—Dermatitis—Lisinopril—systemic scleroderma	0.000556	0.000653	CcSEcCtD
Icosapent ethyl—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000555	0.000651	CcSEcCtD
Icosapent ethyl—Hypertension—Prednisone—systemic scleroderma	0.000555	0.000651	CcSEcCtD
Icosapent ethyl—Chills—Methotrexate—systemic scleroderma	0.000553	0.00065	CcSEcCtD
Icosapent ethyl—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000547	0.000642	CcSEcCtD
Icosapent ethyl—Myalgia—Prednisone—systemic scleroderma	0.000547	0.000642	CcSEcCtD
Icosapent ethyl—Arthralgia—Prednisone—systemic scleroderma	0.000547	0.000642	CcSEcCtD
Icosapent ethyl—Alopecia—Methotrexate—systemic scleroderma	0.000545	0.00064	CcSEcCtD
Icosapent ethyl—Discomfort—Prednisone—systemic scleroderma	0.00054	0.000634	CcSEcCtD
Icosapent ethyl—Malnutrition—Methotrexate—systemic scleroderma	0.000537	0.00063	CcSEcCtD
Icosapent ethyl—Dysgeusia—Methotrexate—systemic scleroderma	0.000526	0.000617	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Prednisone—systemic scleroderma	0.000524	0.000615	CcSEcCtD
Icosapent ethyl—Oedema—Prednisone—systemic scleroderma	0.000524	0.000615	CcSEcCtD
Icosapent ethyl—Infection—Prednisone—systemic scleroderma	0.000521	0.000611	CcSEcCtD
Icosapent ethyl—Back pain—Methotrexate—systemic scleroderma	0.000519	0.00061	CcSEcCtD
Icosapent ethyl—Shock—Prednisone—systemic scleroderma	0.000516	0.000606	CcSEcCtD
Icosapent ethyl—Tachycardia—Prednisone—systemic scleroderma	0.000512	0.000601	CcSEcCtD
Icosapent ethyl—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000511	0.0006	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Prednisone—systemic scleroderma	0.000507	0.000595	CcSEcCtD
Icosapent ethyl—Anorexia—Prednisone—systemic scleroderma	0.0005	0.000587	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000498	0.000585	CcSEcCtD
Icosapent ethyl—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000492	0.000577	CcSEcCtD
Icosapent ethyl—Rash—Mycophenolate mofetil—systemic scleroderma	0.000488	0.000572	CcSEcCtD
Icosapent ethyl—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000487	0.000572	CcSEcCtD
Icosapent ethyl—Malaise—Methotrexate—systemic scleroderma	0.000484	0.000568	CcSEcCtD
Icosapent ethyl—Vertigo—Methotrexate—systemic scleroderma	0.000482	0.000566	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000478	0.000561	CcSEcCtD
Icosapent ethyl—Insomnia—Prednisone—systemic scleroderma	0.000474	0.000557	CcSEcCtD
Icosapent ethyl—Cough—Methotrexate—systemic scleroderma	0.000468	0.00055	CcSEcCtD
Icosapent ethyl—Dyspepsia—Prednisone—systemic scleroderma	0.000461	0.000542	CcSEcCtD
Icosapent ethyl—Chest pain—Methotrexate—systemic scleroderma	0.000457	0.000537	CcSEcCtD
Icosapent ethyl—Myalgia—Methotrexate—systemic scleroderma	0.000457	0.000537	CcSEcCtD
Icosapent ethyl—Arthralgia—Methotrexate—systemic scleroderma	0.000457	0.000537	CcSEcCtD
Icosapent ethyl—Decreased appetite—Prednisone—systemic scleroderma	0.000456	0.000535	CcSEcCtD
Icosapent ethyl—Discomfort—Methotrexate—systemic scleroderma	0.000452	0.00053	CcSEcCtD
Icosapent ethyl—Constipation—Prednisone—systemic scleroderma	0.000448	0.000526	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000438	0.000514	CcSEcCtD
Icosapent ethyl—Infection—Methotrexate—systemic scleroderma	0.000435	0.000511	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Prednisone—systemic scleroderma	0.000432	0.000507	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000423	0.000497	CcSEcCtD
Icosapent ethyl—Anorexia—Methotrexate—systemic scleroderma	0.000418	0.00049	CcSEcCtD
Icosapent ethyl—Body temperature increased—Prednisone—systemic scleroderma	0.000414	0.000487	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000399	0.000469	CcSEcCtD
Icosapent ethyl—Insomnia—Methotrexate—systemic scleroderma	0.000396	0.000465	CcSEcCtD
Icosapent ethyl—Dyspnoea—Methotrexate—systemic scleroderma	0.000391	0.000459	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methotrexate—systemic scleroderma	0.000386	0.000453	CcSEcCtD
Icosapent ethyl—Decreased appetite—Methotrexate—systemic scleroderma	0.000381	0.000447	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000378	0.000444	CcSEcCtD
Icosapent ethyl—Asthenia—Prednisone—systemic scleroderma	0.000376	0.000442	CcSEcCtD
Icosapent ethyl—Pain—Methotrexate—systemic scleroderma	0.000375	0.00044	CcSEcCtD
Icosapent ethyl—Pruritus—Prednisone—systemic scleroderma	0.000371	0.000435	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Methotrexate—systemic scleroderma	0.000361	0.000424	CcSEcCtD
Icosapent ethyl—Dizziness—Prednisone—systemic scleroderma	0.000347	0.000407	CcSEcCtD
Icosapent ethyl—Body temperature increased—Methotrexate—systemic scleroderma	0.000346	0.000407	CcSEcCtD
Icosapent ethyl—Vomiting—Prednisone—systemic scleroderma	0.000333	0.000391	CcSEcCtD
Icosapent ethyl—Rash—Prednisone—systemic scleroderma	0.000331	0.000388	CcSEcCtD
Icosapent ethyl—Dermatitis—Prednisone—systemic scleroderma	0.00033	0.000388	CcSEcCtD
Icosapent ethyl—Asthenia—Methotrexate—systemic scleroderma	0.000314	0.000369	CcSEcCtD
Icosapent ethyl—Pruritus—Methotrexate—systemic scleroderma	0.00031	0.000364	CcSEcCtD
Icosapent ethyl—Dizziness—Methotrexate—systemic scleroderma	0.00029	0.00034	CcSEcCtD
Icosapent ethyl—Vomiting—Methotrexate—systemic scleroderma	0.000279	0.000327	CcSEcCtD
Icosapent ethyl—Rash—Methotrexate—systemic scleroderma	0.000276	0.000324	CcSEcCtD
Icosapent ethyl—Dermatitis—Methotrexate—systemic scleroderma	0.000276	0.000324	CcSEcCtD
